• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病并发症中的炎症:分子机制与治疗干预

Inflammation in diabetes complications: molecular mechanisms and therapeutic interventions.

作者信息

Zhao Lu, Hu Haoran, Zhang Lin, Liu Zheting, Huang Yunchao, Liu Qian, Jin Liang, Zhu Meifei, Zhang Ling

机构信息

Department of Biology and Medicine College of Life Science, Zhejiang Chinese Medical University Hangzhou China.

National Demonstration Center for Experimental Traditional Chinese Medicines Education (Zhejiang Chinese Medical University) College of Pharmaceutical Science, Zhejiang Chinese Medical University Hangzhou China.

出版信息

MedComm (2020). 2024 Apr 12;5(4):e516. doi: 10.1002/mco2.516. eCollection 2024 Apr.

DOI:10.1002/mco2.516
PMID:38617433
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11014467/
Abstract

At present, diabetes mellitus (DM) has been one of the most endangering healthy diseases. Current therapies contain controlling high blood sugar, reducing risk factors like obesity, hypertension, and so on; however, DM patients inevitably and eventually progress into different types of diabetes complications, resulting in poor quality of life. Unfortunately, the clear etiology and pathogenesis of diabetes complications have not been elucidated owing to intricate whole-body systems. The immune system was responsible to regulate homeostasis by triggering or resolving inflammatory response, indicating it may be necessary to diabetes complications. In fact, previous studies have been shown inflammation plays multifunctional roles in the pathogenesis of diabetes complications and is attracting attention to be the meaningful therapeutic strategy. To this end, this review systematically concluded the current studies over the relationships of susceptible diabetes complications (e.g., diabetic cardiomyopathy, diabetic retinopathy, diabetic peripheral neuropathy, and diabetic nephropathy) and inflammation, ranging from immune cell response, cytokines interaction to pathomechanism of organ injury. Besides, we also summarized various therapeutic strategies to improve diabetes complications by target inflammation from special remedies to conventional lifestyle changes. This review will offer a panoramic insight into the mechanisms of diabetes complications from an inflammatory perspective and also discuss contemporary clinical interventions.

摘要

目前,糖尿病已成为最危及健康的疾病之一。当前的治疗方法包括控制高血糖、降低肥胖、高血压等风险因素;然而,糖尿病患者不可避免地最终会发展为不同类型的糖尿病并发症,导致生活质量下降。不幸的是,由于全身系统错综复杂,糖尿病并发症的确切病因和发病机制尚未阐明。免疫系统负责通过触发或解决炎症反应来调节体内平衡,这表明其可能与糖尿病并发症有关。事实上,先前的研究表明炎症在糖尿病并发症的发病机制中发挥着多种作用,并正吸引人们关注其作为有意义的治疗策略。为此,本综述系统地总结了当前关于易患糖尿病并发症(如糖尿病心肌病、糖尿病视网膜病变、糖尿病周围神经病变和糖尿病肾病)与炎症之间关系的研究,范围从免疫细胞反应、细胞因子相互作用到器官损伤的发病机制。此外,我们还总结了各种通过针对炎症来改善糖尿病并发症的治疗策略,从特殊疗法到传统的生活方式改变。本综述将从炎症角度全面深入地探讨糖尿病并发症的机制,并讨论当代临床干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ac/11014467/5ffb82b34cd6/MCO2-5-e516-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ac/11014467/47c47afd8b4c/MCO2-5-e516-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ac/11014467/0a3737d534a9/MCO2-5-e516-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ac/11014467/545f039ca20d/MCO2-5-e516-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ac/11014467/1da659097c77/MCO2-5-e516-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ac/11014467/fbeaee8a1582/MCO2-5-e516-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ac/11014467/5ffb82b34cd6/MCO2-5-e516-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ac/11014467/47c47afd8b4c/MCO2-5-e516-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ac/11014467/0a3737d534a9/MCO2-5-e516-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ac/11014467/545f039ca20d/MCO2-5-e516-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ac/11014467/1da659097c77/MCO2-5-e516-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ac/11014467/fbeaee8a1582/MCO2-5-e516-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ac/11014467/5ffb82b34cd6/MCO2-5-e516-g006.jpg

相似文献

1
Inflammation in diabetes complications: molecular mechanisms and therapeutic interventions.糖尿病并发症中的炎症:分子机制与治疗干预
MedComm (2020). 2024 Apr 12;5(4):e516. doi: 10.1002/mco2.516. eCollection 2024 Apr.
2
Potential Roles of Anti-Inflammatory Plant-Derived Bioactive Compounds Targeting Inflammation in Microvascular Complications of Diabetes.抗炎植物源性生物活性化合物在糖尿病微血管并发症中的潜在作用。
Molecules. 2022 Oct 29;27(21):7352. doi: 10.3390/molecules27217352.
3
Prevalence of Metabolic Syndrome and Its Risk Factors Influence on Microvascular Complications in Patients With Type 1 and Type 2 Diabetes Mellitus.1型和2型糖尿病患者代谢综合征的患病率及其危险因素对微血管并发症的影响
Cureus. 2024 Mar 4;16(3):e55478. doi: 10.7759/cureus.55478. eCollection 2024 Mar.
4
Specialized Pro-resolving Lipid Mediators: Modulation of Diabetes-Associated Cardio-, Reno-, and Retino-Vascular Complications.特殊促消退脂质介质:对糖尿病相关心脏、肾脏和视网膜血管并发症的调节作用
Front Pharmacol. 2018 Dec 19;9:1488. doi: 10.3389/fphar.2018.01488. eCollection 2018.
5
6
NF-ĸB axis in diabetic neuropathy, cardiomyopathy and nephropathy: A roadmap from molecular intervention to therapeutic strategies.糖尿病性神经病变、心肌病和肾病中的核因子-κB轴:从分子干预到治疗策略的路线图
Heliyon. 2024 Apr 18;10(9):e29871. doi: 10.1016/j.heliyon.2024.e29871. eCollection 2024 May 15.
7
Approaches to prevention of cardiovascular complications and events in diabetes mellitus.糖尿病心血管并发症及事件的预防方法。
Drugs. 2007;67(7):997-1026. doi: 10.2165/00003495-200767070-00005.
8
The role of inflammatory cytokines in diabetes and its complications.炎症细胞因子在糖尿病及其并发症中的作用。
J Periodontol. 2008 Aug;79(8 Suppl):1527-34. doi: 10.1902/jop.2008.080246.
9
Genetic associated complications of type 2 diabetes mellitus.2 型糖尿病的遗传相关并发症。
Panminerva Med. 2022 Jun;64(2):274-288. doi: 10.23736/S0031-0808.21.04285-3. Epub 2021 Oct 5.
10
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.1型糖尿病强化血糖控制与传统血糖控制的比较
Cochrane Database Syst Rev. 2014 Feb 14;2014(2):CD009122. doi: 10.1002/14651858.CD009122.pub2.

引用本文的文献

1
[Diabetes mellitus-a risk factor for pain].[糖尿病——疼痛的一个风险因素]
Schmerz. 2025 Aug 28. doi: 10.1007/s00482-025-00900-x.
2
Edible Flowers as Bioactive Food Ingredients with Antidiabetic Potential: A Study on L., × , L., and L.可食用花卉作为具有抗糖尿病潜力的生物活性食品成分:对[具体花卉名称]、[具体花卉名称]、[具体花卉名称]和[具体花卉名称]的研究
Plants (Basel). 2025 Aug 21;14(16):2603. doi: 10.3390/plants14162603.
3
Neurotransmitter Alterations in Prediabetes and Type 2 Diabetes Mellitus: A Narrative Review.前驱糖尿病和2型糖尿病中的神经递质改变:一项叙述性综述

本文引用的文献

1
Assessment of Inner Blood-Retinal Barrier: Animal Models and Methods.内眼血视网膜屏障评估:动物模型与方法。
Cells. 2023 Oct 12;12(20):2443. doi: 10.3390/cells12202443.
2
Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes.特立帕肽和新诊断 1 型糖尿病的β细胞功能。
N Engl J Med. 2023 Dec 7;389(23):2151-2161. doi: 10.1056/NEJMoa2308743. Epub 2023 Oct 18.
3
Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects.糖尿病肾病足细胞损伤:新机制发现与治疗前景。
Int J Mol Sci. 2025 Aug 14;26(16):7847. doi: 10.3390/ijms26167847.
4
Sitagliptin Mitigates Diabetic Cardiomyopathy Through Oxidative Stress Reduction and Suppression of VEGF and FLT-1 Expression in Rats.西他列汀通过减轻氧化应激及抑制大鼠血管内皮生长因子(VEGF)和fms样酪氨酸激酶-1(FLT-1)表达来缓解糖尿病心肌病
Biomolecules. 2025 Jul 30;15(8):1104. doi: 10.3390/biom15081104.
5
Targeted neural stem cell-derived extracellular vesicles loaded with Sinomenine alleviate diabetic peripheral neuropathy via WNT5a/TRPV1 pathway modulation.负载青藤碱的靶向神经干细胞衍生细胞外囊泡通过调节WNT5a/TRPV1通路减轻糖尿病周围神经病变
J Nanobiotechnology. 2025 Aug 26;23(1):588. doi: 10.1186/s12951-025-03678-3.
6
Divergent Interleukin-6 Responses to Hypoglycemia and Hyperglycemia in Adults With Type 1 Diabetes: Insights From Continuous Glucose Monitoring.1型糖尿病成人对低血糖和高血糖的白细胞介素-6反应差异:持续葡萄糖监测的见解
J Diabetes Sci Technol. 2025 Aug 23:19322968251370298. doi: 10.1177/19322968251370298.
7
Integration of Immunometabolic Composite Indices and Machine Learning for Diabetic Retinopathy Risk Stratification: Insights from NHANES 2011 - 2020.免疫代谢复合指标与机器学习相结合用于糖尿病视网膜病变风险分层:来自2011 - 2020年美国国家健康与营养检查调查(NHANES)的见解
Ophthalmol Sci. 2025 Jun 16;5(6):100854. doi: 10.1016/j.xops.2025.100854. eCollection 2025 Nov-Dec.
8
Shared diagnostic genes and potential mechanisms between intervertebral disc degeneration and diabetes mellitus revealed by integrated transcriptomic analysis and machine learning.综合转录组分析和机器学习揭示椎间盘退变与糖尿病之间的共享诊断基因和潜在机制
Front Endocrinol (Lausanne). 2025 Jul 18;16:1576826. doi: 10.3389/fendo.2025.1576826. eCollection 2025.
9
The salvage therapy utilizing human umbilical cord-derived mesenchymal stem cells for the treatment of critically ill patients with COVID-19.利用人脐带间充质干细胞的挽救疗法治疗新冠肺炎危重症患者。
Front Immunol. 2025 Jul 4;16:1594373. doi: 10.3389/fimmu.2025.1594373. eCollection 2025.
10
Targeting NADPH oxidase-driven oxidative stress in diabetic cardiomyopathy: mechanisms and therapeutic perspectives.靶向糖尿病心肌病中NADPH氧化酶驱动的氧化应激:机制与治疗前景
Front Pharmacol. 2025 Jul 3;16:1610429. doi: 10.3389/fphar.2025.1610429. eCollection 2025.
Biomed Pharmacother. 2023 Dec;168:115670. doi: 10.1016/j.biopha.2023.115670. Epub 2023 Oct 13.
4
Vascular complications of diabetes: A narrative review.糖尿病血管并发症:叙述性综述。
Medicine (Baltimore). 2023 Oct 6;102(40):e35285. doi: 10.1097/MD.0000000000035285.
5
[Effects and mechanisms of total flavones of Abelmoschus manihot in improving insulin resistance and podocyte epithelial-mesenchymal transition in diabetic kidney disease based on IRS1/PI3K/Akt pathway].基于IRS1/PI3K/Akt通路探讨黄蜀葵总黄酮改善糖尿病肾病胰岛素抵抗及足细胞上皮-间质转化的作用及机制
Zhongguo Zhong Yao Za Zhi. 2023 May;48(10):2646-2656. doi: 10.19540/j.cnki.cjcmm.20221111.703.
6
Artesunate Inhibits Apoptosis and Promotes Survival in Schwann Cells via the PI3K/AKT/mTOR Axis in Diabetic Peripheral Neuropathy.青蒿琥酯通过 PI3K/AKT/mTOR 轴抑制糖尿病周围神经病变雪旺细胞凋亡并促进其存活。
Biol Pharm Bull. 2023;46(6):764-772. doi: 10.1248/bpb.b22-00619.
7
Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments.肥胖与 2 型糖尿病:流行病学、发病机制和治疗中的关联。
Front Endocrinol (Lausanne). 2023 Apr 21;14:1161521. doi: 10.3389/fendo.2023.1161521. eCollection 2023.
8
Blocking CXC Motif Chemokine Ligand 2 Ameliorates Diabetic Peripheral Neuropathy via Inhibiting Apoptosis and NLRP3 Inflammasome Activation.阻断 CXC 基序趋化因子配体 2 可通过抑制细胞凋亡和 NLRP3 炎性小体激活来改善糖尿病周围神经病变。
Biol Pharm Bull. 2023;46(5):672-683. doi: 10.1248/bpb.b22-00680.
9
Incident type 2 diabetes attributable to suboptimal diet in 184 countries.184 个国家归因于饮食不佳的 2 型糖尿病发病情况。
Nat Med. 2023 Apr;29(4):982-995. doi: 10.1038/s41591-023-02278-8. Epub 2023 Apr 17.
10
Inhibition of the type 1 diabetes candidate gene PTPN2 aggravates TNF-α-induced human beta cell dysfunction and death.抑制 1 型糖尿病候选基因 PTPN2 可加重 TNF-α 诱导的人胰岛β细胞功能障碍和死亡。
Diabetologia. 2023 Aug;66(8):1544-1556. doi: 10.1007/s00125-023-05908-5. Epub 2023 Mar 29.